Norwalk-based IMS Health has launched Ask IMS, a web-based service that provides information to help drive the growth of early-stage biopharmaceutical companies.
“With more than 1,500 biopharmaceutical drugs in active development by early-stage firms, companies are seeking evidence-based insights to develop and integrate commercial thinking early on and throughout the development process,” said Jim Mahon, general manager of product and portfolio management, IMS.
The company is using its pharmaceutical market information to offer support for understanding market opportunities and issues as well as planning and executing commercialization strategies, Mahon said.
“Ask IMS offers an efficient, cost-effective way to transform their scientific vision into market reality,” he said.
“Clients can quickly leverage IMS”™ syndicated market audits for countries worldwide, focusing on critical areas such as sales and prescribing trends, primary disease treatments and promotion activities in specific markets. Answers to client queries are delivered in pre-formatted, presentation-ready reports that can be customized for a variety of uses.”
